New pill tested for severe asthma that inhalers Can't control

NCT ID NCT07323654

Recruiting now Disease control Sponsor: Kymera Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral medication called KT-621 for adults with a specific type of moderate-to-severe asthma that remains uncontrolled despite using standard high-dose inhaler medications. Researchers aim to see if the pill improves lung function and asthma control while monitoring its safety. The trial will enroll 264 participants and compare several doses of KT-621 against a placebo pill.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Kymera Investigative Site
RECRUITING

Upland, California, 91786, United States
Kymera Investigative Site
RECRUITING

Miami, Florida, 33126, United States
Kymera Investigative Site
RECRUITING

Tampa, Florida, 33607, United States
Kymera Investigative Site
RECRUITING

East Point, Georgia, 30344, United States
Kymera Investigative Site
RECRUITING

Edmond, Oklahoma, 73034, United States
Kymera Investigative Site
RECRUITING

Clackamas, Oregon, 97015, United States
Kymera Investigative Site
RECRUITING

Pittsburgh, Pennsylvania, 15241, United States
Kymera Investigative Site
RECRUITING

North Charleston, South Carolina, 29406, United States
Kymera Investigative Site
RECRUITING

Chattanooga, Tennessee, 37403, United States

Conditions

Explore the condition pages connected to this study.

EOSINOPHILIC ASTHMA